Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 18 of 114

  1. BB2121-MM-003

    Celgene Europe Limited

    Multiple myeloma (MM) with at least 2 prior therapies including an immunomodulatory (IMiD) compound and a proteasome inhibitor (PI) and demonstrated disease progression on or within 60 days of completion of the last therapy.

    phase 3 small molecule active

    1 trial

  2. BCA101X301

    Bicara Therapeutics

    Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

    phase 3 small molecule active

    1 trial

  3. BCG (Tokyo 172) vaccine

    United Therapeutics Europe Ltd

    Tuberculosis Infection

    phase 3 mab terminated

    1 trial

  4. BCX4161

    Biocryst

    Hereditary Angioedema

    phase 3 small molecule completed

    4 trials

  5. BCX7353

    Biocryst

    Hereditary Angioedema

    phase 3 small molecule completed

    4 trials

  6. BCX7353 capsules

    Biocryst

    Hereditary Angioedema

    phase 3 small molecule completed

    1 trial

  7. BCX7353 capsules

    Biocryst

    Hereditary Angioedema, HAE

    phase 3 small molecule completed

    1 trial

  8. BCX7353-304

    Lacuna Pharma Pty Ltd

    Hereditary Angioedema (HAE)

    phase 3 small molecule active

    1 trial

  9. BDP

    Teva Pharma GmbH

    Allergic Rhinitis

    phase 3 small molecule completed

    1 trial

  10. BDP HFA

    Teva Pharma GmbH

    Seasonal Allergic Rhinitis

    phase 3 small molecule completed

    1 trial

  11. BDP Nasal Aerosol

    Teva Pharma GmbH

    Allergic Rhinitis

    phase 3 small molecule completed

    1 trial

  12. BE1116

    CSL Behring GmbH

    Complex Cardiovascular Surgery With Cardiopulmonary Bypass

    phase 3 mab active

    1 trial

  13. BEATcc

    Ningbo Cancer Hospital

    Metastatic (stage IVB), Persistent, or Recurrent Carcinoma of the Cervix

    phase 3 small molecule active

    1 trial

  14. BEP(500)

    United Therapeutics Europe Ltd

    Stage I Testicular Non-Seminomatous Germ Cell Tumor

    phase 3 small molecule completed

    1 trial

  15. BEVACIZUMAB, ERLOTINIB

    Fondazione Telethon ETS

    Non-squamous Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  16. BG00012

    Biogen

    Relapsing-Remitting Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  17. BGB-11417 for Previously Untreated Chronic Lymphocytic Leukemia

    BEONE MEDICINES AUS PTY LTD

    Previously Untreated Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

  18. BGB-11417-302

    BEONE MEDICINES AUS PTY LTD

    relapsed or refractory mantle cell lymphoma (R/R MCL)

    phase 3 small molecule active

    1 trial

  19. BGB-11417-303CLL-RR1

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    phase 3 small molecule active

    1 trial

  20. BGB-11417-304

    BEONE MEDICINES AUS PTY LTD

    treatment-naive Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

  21. BGB-16673

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    2 trials

  22. BGB-16673

    BEONE MEDICINES AUS PTY LTD

    CLL

    phase 3 small molecule active

    1 trial

  23. BGB-16673-302

    BEONE MEDICINES AUS PTY LTD

    Chronic lymphotic leukemia and Small Lymphocytic lymphoma

    phase 3 small molecule active

    1 trial

  24. BGB-16673-304

    BEONE MEDICINES AUS PTY LTD

    Chronic lymphocytic leukemia (CLL), Small lymphocytic lymphoma (SLL)

    phase 3 small molecule active

    1 trial

  25. BGB-3111

    BeiGene

    Waldenström's Macroglobulinemia

    phase 3 small molecule completed

    1 trial

  26. BGB-3111-304

    BEONE MEDICINES AUS PTY LTD

    Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    phase 3 small molecule active

    1 trial

  27. BGB-3111-306

    BEONE MEDICINES AUS PTY LTD

    Mantle Cell Lymphoma

    phase 3 small molecule active

    1 trial

  28. BGB-43395

    BEONE MEDICINES AUS PTY LTD

    HR+/HER2- Breast Cancer

    phase 3 small molecule active

    1 trial

  29. BGB-A317-290-LTE1

    BEONE MEDICINES AUS PTY LTD

    Solid tumors and hamatological malignancies

    phase 3 small molecule active

    1 trial

  30. BGB-A317-316

    BEONE MEDICINES AUS PTY LTD

    Locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma

    phase 3 small molecule active

    1 trial

  31. BGB-A317-A1217-302

    BeiGene

    Locally advanced, unresectable, or metastatic non small cell lung cancer

    phase 3 small molecule active

    1 trial

  32. BGF MDI 320/14.4/9.6 μg

    AstraZeneca

    COPD (Chronic Obstructive Pulmonary Disease)

    phase 3 small molecule active

    1 trial

  33. BGF MDI 320/28.8/9.6 μg

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  34. BGF MDI HFO 320/14.4/9.6μg

    AstraZeneca

    COPD (Chronic Obstructive Pulmonary Disease)

    phase 3 small molecule completed

    1 trial

  35. BGJ398

    BridgeBio Oncology Therapeutics

    Advanced Cholangiocarcinoma

    phase 3 small molecule terminated

    1 trial

  36. BHV2000-301

    Lacuna Pharma Pty Ltd

    Spinal Muscular Atrophy

    phase 3 small molecule active

    1 trial

  37. BHV4157-303

    Lacuna Pharma Pty Ltd

    Obsessive Compulsive Disorder

    phase 3 small molecule active

    1 trial

  38. BHV7000-303

    Biohaven Bioscience Ireland Limited

    Refractory Focal Onset Epilepsy

    phase 3 small molecule active

    1 trial

  39. BHV7000-304

    Biohaven Bioscience Ireland Limited

    Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures

    phase 3 small molecule active

    1 trial

  40. BHV8000-301

    Biohaven Bioscience Ireland Limited

    Early Parkinson’s Disease

    phase 3 small molecule active

    1 trial

  41. BI 1015550, BI 1015550

    Boehringer Ingelheim

    idiopathic pulmonary fibrosis (IPF), progressive pulmonary fibrosis (PPF)

    phase 3 small molecule active

    1 trial

  42. BI 10773

    Boehringer Ingelheim

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  43. BI 1291583

    Boehringer Ingelheim

    Bronchiectasis

    phase 3 small molecule active

    1 trial

  44. BI 201335

    Boehringer Ingelheim

    Hepatitis C, Chronic

    phase 3 small molecule completed

    1 trial

  45. BI 201335

    Boehringer Ingelheim

    Hepatitis C

    phase 3 small molecule completed

    1 trial

  46. BI 695501

    Boehringer Ingelheim

    Arthritis, Rheumatoid

    phase 3 small molecule completed

    2 trials

  47. BI 764198

    Boehringer Ingelheim

    Focal Segmental Glomerulosclerosis

    phase 3 small molecule active

    1 trial

  48. BI 764198, Placebo matching BI 764198

    Boehringer Ingelheim

    Focal segmental glomerulosclerosis

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.